- Home
- MDAI vs ICCM Comparison
MDAI vs ICCM Comparison
Compare MDAI & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- ICCM
- Stock Information
- Founded
- MDAI 2013
- ICCM 2006
- Country
- MDAI United States
- ICCM Israel
- Employees
- MDAI N/A
- ICCM N/A
- Industry
- MDAI Medical/Dental Instruments
- ICCM
- Sector
- MDAI Health Care
- ICCM
- Exchange
- MDAI Nasdaq
- ICCM Nasdaq
- Market Cap
- MDAI 55.9M
- ICCM 49.1M
- IPO Year
- MDAI N/A
- ICCM N/A
- Fundamental
- Price
- MDAI $1.33
- ICCM $0.61
- Analyst Decision
- MDAI Strong Buy
- ICCM Strong Buy
- Analyst Count
- MDAI 2
- ICCM 1
- Target Price
- MDAI $3.25
- ICCM $2.50
- AVG Volume (30 Days)
- MDAI 554.9K
- ICCM 445.9K
- Earning Date
- MDAI 11-11-2025
- ICCM 11-19-2025
- Dividend Yield
- MDAI N/A
- ICCM N/A
- EPS Growth
- MDAI N/A
- ICCM N/A
- EPS
- MDAI N/A
- ICCM N/A
- Revenue
- MDAI $23,168,000.00
- ICCM $2,975,000.00
- Revenue This Year
- MDAI N/A
- ICCM $2.92
- Revenue Next Year
- MDAI $60.05
- ICCM $57.81
- P/E Ratio
- MDAI N/A
- ICCM N/A
- Revenue Growth
- MDAI N/A
- ICCM N/A
- 52 Week Low
- MDAI $1.01
- ICCM $0.56
- 52 Week High
- MDAI $3.25
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- MDAI 24.84
- ICCM 26.09
- Support Level
- MDAI $1.38
- ICCM $0.69
- Resistance Level
- MDAI $1.55
- ICCM $0.75
- Average True Range (ATR)
- MDAI 0.13
- ICCM 0.04
- MACD
- MDAI -0.05
- ICCM 0.00
- Stochastic Oscillator
- MDAI 1.37
- ICCM 15.31
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.